Who
Kathryn K. Rowen
EVP Chief Transf. & Op Officer
Company insider
Files Form 4 as: EVP Chief Transf. & Op Officer, Vontier.
In numbers
- Trades disclosed
- 64
- Buys
- 1
- Sells
- 2
- Bought
- $26K
- Sold
- $1.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Oct 2020
- Last trade
- 24 Mar 2026
- Last filed
- 25 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Mar 2026filed 25 Mar 2026 | VNT Vontieroption or derivative · Life-science tools | SEC FORM 4 Code A | $70K1,895.37 at $36.93 | filing |
| 24 Mar 2026filed 25 Mar 2026 | VNT Vontieroption or derivative · Life-science tools | SEC FORM 4 Code A | $70K1,895.37 at $36.93 | filing |
| 27 Feb 2026filed 3 Mar 2026 | VNT VontierLife-science tools | SEC FORM 4 Code F | $121K2,960 at $40.92 | filing |
| 27 Feb 2026filed 3 Mar 2026 | VNT VontierLife-science tools | SEC FORM 4 Code F | $121K2,960 at $40.92 | filing |
| 19 Feb 2026filed 20 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Code F | $88K2,158 at $41.01 | filing |
| 19 Feb 2026filed 20 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Code F | $88K2,158 at $41.01 | filing |
| 17 Feb 2026filed 18 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Sold | $468K11,264 at $41.54 | filing |
| 17 Feb 2026filed 18 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Sold | $468K11,264 at $41.54 | filing |
| 16 Feb 2026filed 18 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Code A | —16,645 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Code A | —7,593 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | VNT Vontieroption or derivative · Life-science tools | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | VNT Vontieroption or derivative · Life-science tools | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Code A | —16,645 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Code A | —7,593 at $0.00 | filing |
| 13 Feb 2026filed 18 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Code F | $100K2,381 at $41.79 | filing |
| 13 Feb 2026filed 18 Feb 2026 | VNT VontierLife-science tools | SEC FORM 4 Code F | $100K2,381 at $41.79 | filing |
| 15 Aug 2025filed 18 Aug 2025 | VNT VontierLife-science tools | SEC FORM 4 Code F | $28K667 at $42.11 | filing |
| 12 May 2025filed 13 May 2025 | VNT VontierLife-science tools | SEC FORM 4 Sold | $267K7,344 at $36.34 | filing |
| 28 Feb 2025filed 3 Mar 2025 | VNT VontierLife-science tools | SEC FORM 4 Code F | $214K5,728 at $37.35 | filing |
| 20 Feb 2025filed 21 Feb 2025 | VNT VontierLife-science tools | SEC FORM 4 Code F | $24K622 at $38.62 | filing |
News
Vontier Corporation (NYSE:VNT) Stock Has Average Price Target of $41.00VNT · dailypolitical.com · 16 Oct 2026
0 headlines in the last 90 days name Kathryn K. Rowen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.